Merck commits up to $1 billion to Google Cloud partnership to accelerate AI across its operations

Merck announced a multiyear partnership with Google Cloud, investing up to $1 billion to embed AI tools throughout its research, development, manufacturing, commercial and corporate functions.

The collaboration reflects a broader trend of large pharma companies adopting AI to speed drug discovery and improve operational efficiency.

In a separate development, the FDA cleared Merck’s new two‑drug HIV combination, Idvynso, for use as a replacement therapy in adults whose viral load is already suppressed by existing regimens.